New Blood Test Offers Option for Colorectal Cancer Screening
Guardant Health, Inc., has announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cancer screening. This approval marks a significant milestone, as Shield is the first blood test approved by the FDA as a primary screening option for colorectal cancer. Dr. Michael Kaczanowski, a board-certified gastroenterologist…